{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:51:10Z","timestamp":1790664670279,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T00:00:00Z","timestamp":1443139200000},"content-version":"vor","delay-in-days":632,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 GM091743"],"award-info":[{"award-number":["P01 GM091743"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI064046"],"award-info":[{"award-number":["R01 AI064046"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.virol.2013.11.004","type":"journal-article","created":{"date-parts":[[2013,11,25]],"date-time":"2013-11-25T23:30:50Z","timestamp":1385422250000},"page":"82-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Defining HIV-1 Vif residues that interact with CBF\u03b2 by site-directed mutagenesis"],"prefix":"10.1016","volume":"449","author":[{"given":"Yusuke","family":"Matsui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Io","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumie","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimitsu","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.virol.2013.11.004_bib1","doi-asserted-by":"crossref","first-page":"10209","DOI":"10.1128\/JVI.00632-10","article-title":"Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function","volume":"84","author":"Albin","year":"2010","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2013.11.004_bib190","doi-asserted-by":"crossref","first-page":"e1000925","DOI":"10.1371\/journal.ppat.1000925","article-title":"The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex","volume":"6","author":"Bergeron","year":"2010","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.virol.2013.11.004_bib2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nsmb1086","article-title":"APOBEC3G DNA deaminase acts processively 3\u2032\u21925\u2032 on single-stranded DNA","volume":"13","author":"Chelico","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"17","key":"10.1016\/j.virol.2013.11.004_bib3","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1128\/JVI.00653-09","article-title":"A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G","volume":"83","author":"Chen","year":"2009","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virol.2013.11.004_bib4","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1128\/JVI.00079-10","article-title":"Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity","volume":"84","author":"Dang","year":"2010","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.virol.2013.11.004_bib5","doi-asserted-by":"crossref","first-page":"8544","DOI":"10.1128\/JVI.00651-09","article-title":"Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization","volume":"83","author":"Dang","year":"2009","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2013.11.004_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbrc.2004.01.023","article-title":"The Vif protein of human immunodeficiency virus type 1 is posttranslationally modified by ubiquitin","volume":"315","author":"Dussart","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.virol.2013.11.004_bib7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.micinf.2004.04.011","article-title":"Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation","volume":"6","author":"Fujita","year":"2004","journal-title":"Microb. Infect."},{"issue":"2","key":"10.1016\/j.virol.2013.11.004_bib8","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1128\/JVI.77.2.1626-1632.2003","article-title":"Amino acid residues 88 and 89 in the central hydrophilic region of human immunodeficiency virus type 1 Vif are critical for viral infectivity by enhancing the steady-state expression of Vif","volume":"77","author":"Fujita","year":"2003","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virol.2013.11.004_bib9","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1128\/jvi.66.11.6489-6495.1992","article-title":"Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes","volume":"66","author":"Gabuzda","year":"1992","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virol.2013.11.004_bib10","first-page":"908","article-title":"Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte\/macrophages","volume":"7","author":"Gabuzda","year":"1994","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"11","key":"10.1016\/j.virol.2013.11.004_bib11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cub.2008.04.073","article-title":"Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3G","volume":"18","author":"Hach\u00e9","year":"2008","journal-title":"Curr. Biol."},{"issue":"6","key":"10.1016\/j.virol.2013.11.004_bib12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","article-title":"DNA deamination mediates innate immunity to retroviral infection","volume":"113","author":"Harris","year":"2003","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.virol.2013.11.004_bib13","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jmb.2008.06.061","article-title":"Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction","volume":"381","author":"He","year":"2008","journal-title":"J. Mol. Biol."},{"issue":"5","key":"10.1016\/j.virol.2013.11.004_bib14","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1128\/JVI.06950-11","article-title":"Vif proteins of human and simian immunodeficiency viruses require cellular CBFbeta to degrade APOBEC3 restriction factors","volume":"86","author":"Hultquist","year":"2011","journal-title":"J, Virol,"},{"issue":"21","key":"10.1016\/j.virol.2013.11.004_bib15","doi-asserted-by":"crossref","first-page":"11220","DOI":"10.1128\/JVI.05238-11","article-title":"Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1","volume":"85","author":"Hultquist","year":"2011","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virol.2013.11.004_bib16","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1089\/aid.2012.0142","article-title":"HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor beta on genetically distinct surfaces","volume":"28","author":"Hultquist","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2013.11.004_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-4690-6-1","article-title":"MDM2 is a novel E3 ligase for HIV-1 Vif","volume":"6","author":"Izumi","year":"2009","journal-title":"Retrovirology"},{"issue":"7381","key":"10.1016\/j.virol.2013.11.004_bib18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature10693","article-title":"Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection","volume":"481","author":"J\u00e4ger","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.virol.2013.11.004_bib19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.molcel.2012.12.012","article-title":"CBFbeta stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression","volume":"49","author":"Kim","year":"2013","journal-title":"Mol. Cell"},{"issue":"32","key":"10.1016\/j.virol.2013.11.004_bib20","doi-asserted-by":"crossref","first-page":"11444","DOI":"10.1073\/pnas.0502440102","article-title":"Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G","volume":"102","author":"Luo","year":"2005","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"issue":"11","key":"10.1016\/j.virol.2013.11.004_bib21","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nm946","article-title":"HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation","volume":"9","author":"Marin","year":"2003","journal-title":"Nat. Med."},{"issue":"23","key":"10.1016\/j.virol.2013.11.004_bib22","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1101\/gad.1249904","article-title":"Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation","volume":"18","author":"Mehle","year":"2004","journal-title":"Genes Dev."},{"issue":"25","key":"10.1016\/j.virol.2013.11.004_bib23","doi-asserted-by":"crossref","first-page":"17259","DOI":"10.1074\/jbc.M602413200","article-title":"A zinc-binding region in Vif binds Cul5 and determines cullin selection","volume":"281","author":"Mehle","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.virol.2013.11.004_bib24","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1128\/JVI.01898-08","article-title":"Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif","volume":"83","author":"Pery","year":"2009","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.virol.2013.11.004_bib25","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.1128\/JVI.00395-07","article-title":"Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F","volume":"81","author":"Russell","year":"2007","journal-title":"J. Virol."},{"issue":"6898","key":"10.1016\/j.virol.2013.11.004_bib26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature00939","article-title":"Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein","volume":"418","author":"Sheehy","year":"2002","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.virol.2013.11.004_bib27","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/nm945","article-title":"The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif","volume":"9","author":"Sheehy","year":"2003","journal-title":"Nat. Med."},{"issue":"45","key":"10.1016\/j.virol.2013.11.004_bib28","doi-asserted-by":"crossref","first-page":"44412","DOI":"10.1074\/jbc.C300376200","article-title":"The enzymatic activity of CEM15\/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity","volume":"278","author":"Shindo","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.virol.2013.11.004_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.virol.2005.10.028","article-title":"Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex","volume":"344","author":"Shirakawa","year":"2006","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.virol.2013.11.004_bib30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1097-2765(03)00353-8","article-title":"HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability","volume":"12","author":"Stopak","year":"2003","journal-title":"Mol. Cell"},{"issue":"14","key":"10.1016\/j.virol.2013.11.004_bib191","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.1128\/JVI.00031-10","article-title":"Dissection of the HIV Vif interaction with human E3 ubiquitin ligase","volume":"84","author":"Wolfe","year":"2010","journal-title":"J Virol"},{"issue":"5647","key":"10.1016\/j.virol.2013.11.004_bib31","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.1089591","article-title":"Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex","volume":"302","author":"Yu","year":"2003","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.virol.2013.11.004_bib32","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1101\/gad.1250204","article-title":"Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines","volume":"18","author":"Yu","year":"2004","journal-title":"Genes Dev."},{"issue":"6944","key":"10.1016\/j.virol.2013.11.004_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature01707","article-title":"The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA","volume":"424","author":"Zhang","year":"2003","journal-title":"Nature"},{"issue":"7381","key":"10.1016\/j.virol.2013.11.004_bib34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature10718","article-title":"T-cell differentiation factor CBF-beta regulates HIV-1 Vif-mediated evasion of host restriction","volume":"481","author":"Zhang","year":"2011","journal-title":"Nature"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268221300617X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268221300617X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:22:16Z","timestamp":1758586936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268221300617X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":36,"alternative-id":["S004268221300617X"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2013.11.004","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining HIV-1 Vif residues that interact with CBF\u03b2 by site-directed mutagenesis","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2013.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}